INSIGHTS ON CLINICAL TRIAL DESIGN

• Mastering Precision Oncology Start-Up: Reducing Screening Delays

  Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.

• Investigational Insights: Elevating IDS Practice Through Continuing Education

  Discover how leading IDS teams are using automation and standardized digital workflows to streamline protocol management, reduce errors, improve efficiency, and strengthen research operations.

• Evolving IRT For Today's Trials: Flexibility, Site Experience, And Integrated Workflow

  Interactive Response Technology is evolving beyond traditional randomization and trial supply management to help guide protocol workflows in increasingly complex studies.

• Your Biggest Unblinding Risk? Inexperienced Staff

  Protect study integrity by closing the gaps in IRT workflows. Learn why rushed communication and training lapses lead to accidental unblinding and how to safeguard your clinical data.

• Early Planning Makes Clinical Research Meetings More Effective

  3/20/2026

  Starting earlier can dramatically improve clinical research meetings. Explore how timing affects your choices and why identifying non-negotiables first helps teams manage meeting budgets.

• Improving Rare Disease Recruitment With Data And AI

  4/15/2026

  Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.

• The Strategic Backbone Of Marketing Application Success

  3/12/2025

  Through proactive timeline management and strategic oversight, organizations can achieve their regulatory goals with confidence.

• Recruitment Readiness: From The Front Lines To First-In-Patient

  4/10/2025

  Operating within local markets, LES professionals conduct meticulous eligibility assessments, manage referrals, and facilitate patient navigation, ensuring a seamless pre-screening experience.

• Balancing Speed And Risk In Early Oncology Development

  10/16/2026

  Oncology trials are more complex than ever. Learn how lean biotech teams can balance speed and risk by making smarter early decisions on study design, trial sites, and patient enrollment.